Liposome Drug Delivery Market Trends

Growth Drivers

• Rising Prevalence of Cancer Globally – Liposome drug delivery is widely used in the treatment of cancer owing to its wide range of advantages and properties. In 2020, 10 million people died out of cancer all over the globe and 5 million new cases were recorded. 
• Growing Significance of Liposomes as a Drug Delivery System - Owing to the importance of liposomes in drug delivery, numerous studies, and clinical trials are ongoing and positive results from these sources are expected to continue to have a positive impact on the growth of the liposome drug delivery market under study. According to the study "Inhaled Liposomal Antimicrobial Delivery in Pulmonary Infections" published in July 2020, the use of inhaled liposomal antimicrobial therapy in pulmonary infections resulted in the antimicrobial agent targeting the infective organisms at the site of infection, thereby increasing the intracellular antibiotic concentration. It reduces drug toxicity and improves tolerability. 
• Increased Use of Quality by Design (QbD) Over Traditional Methods- As a consequence of the popularity of rational-based methods like QbD over empirical and simulation-based techniques, procedures have been upgraded. In contrast to traditional techniques that rely on trial and error, QbD is based on a fact-based rational strategy that allows for superior decision-making. The popularity and application of the QbD approach are expected to propel market growth.

Challenges

• High Cost of Development of the Drug Delivery System – Liposome drug delivery can be expensive and can limit access for patients who cannot afford it. This can be a particularly big challenge in developing countries with limited healthcare budgets. 
• Limited Clinical Data
• Competition from Drug Delivery Technologies